Repeated attempts to tackle antimicrobial resistance (AMR) have failed to make much of an impact, but hope springs eternal and the European Commission is throwing its weight behind a combination of incentives and cuts in antibiotic consumption that it hopes will help tackle what it calls “one of the top three health threats” facing the EU.
As part of the legislative reform package published on 26 April, the commission is putting forward a key pull incentive for the development of new antimicrobials: the use of transferable data exclusivity vouchers over a 15-year period
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?